---
title: "Kengic: Net loss of 58.6268 million yuan in 2024"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237594559.md"
description: "Kengic announced that the operating revenue for 2024 is expected to be 1.394 billion yuan, a year-on-year increase of 21.35%. The net loss attributable to shareholders of the listed company is expected to be 58.6268 million yuan, compared to a net loss of 77.9291 million yuan in the same period last year. The company plans not to distribute cash dividends, not to issue bonus shares, and not to increase capital stock from the capital reserve in 2024"
datetime: "2025-04-25T14:30:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237594559.md)
  - [en](https://longbridge.com/en/news/237594559.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237594559.md)
generator: "portal-rs"
---

# Kengic: Net loss of 58.6268 million yuan in 2024

Kengic announced that the operating revenue for 2024 is expected to be 1.394 billion yuan, a year-on-year increase of 21.35%. The net loss attributable to shareholders of the listed company is 58.6268 million yuan, compared to a net loss of 77.9291 million yuan in the same period last year. The company plans not to distribute cash dividends, not to issue bonus shares, and not to increase capital stock from capital reserves in 2024

### Related Stocks

- [688455.CN](https://longbridge.com/en/quote/688455.CN.md)

## Related News & Research

- [Pony.ai signs freight forwarding services deal with Sinotrans Supply Chain](https://longbridge.com/en/news/296900483.md)
- [China’s CXMT hits a DRAM production ceiling as global memory prices keep climbing](https://longbridge.com/en/news/296858852.md)
- [Private Assets combines Kieler Maschinenwerke, Pro-Valve under Kiel Power Systems SE](https://longbridge.com/en/news/296999688.md)
- [Couche-Tard launches tender offer for all Zabka shares](https://longbridge.com/en/news/296992800.md)
- [Implantica to host Capital Markets Day after RefluxStop FDA approval](https://longbridge.com/en/news/296865775.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**